Search results
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 5 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 6 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 13 hours agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Los Angeles· 6 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 5 days ago19, in an advanced clinical trial that included adults ages 50 and older. The ongoing clinical trial...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 5 days agoNovavax's candidate already has delivered positive results from its phase 2 trial and the company...
Innovation, Partnerships & Progress: How Life Sciences Is Booming in Maryland’s Montgomery County
FierceBiotech· 6 days agoDrive or take the metro in any direction within Montgomery County, Maryland, and you'll come across...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 2 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoAnd Moderna stock surged more than 9% on Dec. 19, the day it released the news. Moderna also...